decisionhealth Newsletters, Part B News - 2012 Issue 9 (September)
Ask a Part B News expert: Billing Procrit as a primary care practice
Subscribe or sign in to view the full article.
Article Overview
This Q&A article focuses on Medicare Part B billing issues for Procrit (epoetin alfa) when used for patients without ESRD, with additional discussion of how reporting requirements may differ for certain facility types. It summarizes CMS-related guidance on claim submission elements, lab-result reporting, and related administrative requirements that affect reimbursement and claim processing. The article is aimed at coders, billing staff, and practices that administer ESA therapy and want to understand the general compliance framework.
Why This Topic Matters
ESA claims are highly sensitive to claim-format and documentation requirements, so missing reporting elements can lead to denials or returned claims. Understanding the billing workflow helps practices reduce rejections and improve compliance with Medicare submission rules.
Article Sections
-
Question and scenario
Introduces the billing question, the clinical setting, and the general claim setup being reviewed. It frames the Medicare and facility-context concerns addressed in the article.
-
Answer and common denial issues
Summarizes the expert response and highlights the broad categories of claim issues that can trigger denials for this type of service. The section also points readers to the relevant Medicare manual guidance.
-
CMS guidance on hematocrit and hemoglobin reporting
Reviews the CMS reporting requirements for lab results on claims for ESA-related services. It distinguishes among institutional, paper professional, and electronic claim submission methods.
-
CMS guidance on modifiers for non-ESRD ESA claims
Reviews CMS guidance on modifier reporting requirements for non-ESRD ESA claims and the related claim-processing consequences. It also notes the administrative follow-up referenced in the article.
-
Submission note and disclaimer
Provides contact information for submitting future questions and a brief disclaimer about the expert opinions expressed. This section is administrative rather than coding guidance.
What You Will Learn
- The general Medicare Part B billing context for ESA therapy in non-ESRD patients
- How claim reporting requirements differ by claim type and submission method
- What broad categories of documentation and claim elements are emphasized for ESA-related services
- Which administrative guidance sources are referenced in the discussion
Who Should Read This
- Medical coders
- Billing staff
- Primary care practices
- Medicare providers
- Revenue cycle teams
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com